News

West Pharmaceutical Services’s (NYSE:WST) Q4: Beats On Revenue But Stock Drops

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 2.3% year on year to $748.8 million. On the other hand, the company’s full-year revenue guidance of $2.89 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $1.82 per share was 5.3% above analysts’ consensus estimates.

Morning Bid: Peace and prices - inflation vies with Ukraine talks

Talks to end the Ukraine war have partly cut across the hot U.S. inflation report for world markets, reining in both oil prices and capping aggravated U.S. borrowing rates - while also lifting the euro and European shares. Long-flagged by U.S. President Donald Trump as a priority, Wednesday's news that he spoke with Russian President Vladimir Putin and Ukrainian President Volodymyr Zelenskiy on talks to end the war dragged crude oil lower. With Russia still the world's third-largest oil producer, the prospect of some future lifting of sanctions on its crude exports saw U.S. oil prices fall back to $70 per barrel and close to the year's lows - down some 4% from Tuesday's close.

Here's Why Bitcoin Could Soon Get a Big Boost

This could be a sign of some apprehension in the markets about Trump's prposed tariffs and their effect on the economy. According to a report from Bloomberg, top asset management firm BlackRock is looking at launching a Bitcoin ETP in Europe soon. It would be the first European crypto ETP, and it could lead to many more such ETPs.

Himax (NASDAQ:HIMX) Delivers Strong Q4 Numbers, Stock Jumps 10.5%

Semiconductor maker Himax Technologies (NASDAQ:HIMX) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 4.2% year on year to $237.2 million. On top of that, next quarter’s revenue guidance ($212.3 million at the midpoint) was surprisingly good and 5.8% above what analysts were expecting. Its GAAP profit of $0.14 per share was 40% above analysts’ consensus estimates.

Wall Street ends higher after Trump unveils tariff plan

(Reuters) -The S&P 500 ended higher on Thursday, lifted by gains in Nvidia, Apple and Tesla, after U.S. President Donald Trump unveiled a roadmap for charging reciprocal tariffs on U.S. trading partners. A White House official said the tariffs would match the higher duties charged by other countries and could be imposed within weeks as Trump's trade and economic team studies bilateral tariff and trade relationships. Healthcare, with a nearly 20% weighting in the core PCE, declined 0.06%.